We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Ambulance-Administered Coronary Reperfusion Is Effective

By HospiMedica International staff writers
Posted on 14 Sep 2014
Print article
A new study shows that administration of a platelet inhibitor during transport to hospital produces better results following hospital percutaneous coronary intervention (PCI).

Researchers at Pitie-Salpetriere Hospital (Paris, France), Sheffield University (United Kingdom), and other institutions conducted a randomized, double-blind study involving 1,862 patients with ongoing ST-segment elevation myocardial infarction (STEMI) of less than 6 hours' duration, comparing ambulance and in-hospital (catheterization laboratory) treatment with ticagrelor, a platelet aggregation inhibitor produced by AstraZeneca. Co-primary end points were the proportion of patients who did not have a 70% or greater resolution of STEMI before PCI, and the proportion of patients who did not have thrombolysis in the infarct-related artery at initial angiography.

The results showed that the median time from randomization to PCI angiography was 48 minutes, with the median time difference between the two treatment strategies 31 minutes. No significant disparities were found in end point difference, major adverse cardiovascular events, or major bleeding events between groups, but the rates of definite stent thrombosis were lower in the pre-hospital group than in the in-hospital group. The study was published on September 1, 2014, in the New England Journal of Medicine (NEJM).

“Ambulance administration is safe, and may even reduce the risk of post-PCI stent thrombosis. Our study shows there is no downside to the earlier administration of ticagrelor, and it reduces the risk of post-procedure stent thrombosis, which is a serious iatrogenic complication,” said lead author Gilles Montalescot, MD, PhD, of Pitie-Salpetriere Hospital. “The ambulance is also a more practical location for drug administration than the cath lab.”

Ticagrelor blocks adenosine diphosphate (ADP) receptors of subtype P2Y12. In contrast to the other antiplatelet drugs, ticagrelor has a binding site different from ADP, making it an allosteric antagonist, and thus the blockage is reversible. Moreover, the drug does not need hepatic activation. Studies have shown that ticagrelor has lower mortality rates than clopidogrel in treating patients with acute coronary syndrome (ACS), who were less likely to die from vascular causes, heart attack, or stroke, but had greater chances bleeding.

Related Links:

Pitie-Salpetriere Hospital
Sheffield University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Breast Imaging Workstation
SecurView

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.